Skip to main content
Equibles

Ameritas Investment Partners, Inc.

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 1055980 LINCOLN, NE
Back to GLSI Full portfolio

Position in GLSI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,724
-$327 QoQ
Shares Held
585
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 57 holders
Holding Since
Jun 2021
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GLSI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ameritas Investment Partners, Inc. holds $63,306,181 across 267 Biotechnology names. GLSI ranks #235 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 12,422 $6,170,379
2 EXEL
Exelixis, Inc.
 75,969 $4,133,473
3 HALO
Halozyme Therapeutics, Inc.
 40,729 $3,187,858
4 CYTK
Cytokinetics Inc
 36,992 $3,151,348
5 ROIV
Roivant Sciences Ltd.
 83,064 $2,939,634
6 REGN
Regeneron Pharmaceuticals, Inc.
 4,593 $2,863,919
7 JAZZ
Jazz Pharmaceuticals plc
 11,547 $2,782,480
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 25,923 $2,112,983

All Filings in GLSI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,724 585
2026-03-31 $14,051 585
2025-12-31 $12,290 585
2025-09-30 $5,820 585
2025-06-30 $5,305 585
2025-03-31 $5,580 585
2024-12-31 $6,569 585
2024-09-30 $8,406 585
2024-06-30 $10,097 585
2022-03-31 $6,199 316
2021-12-31 $7,688 316
2021-09-30 $12,346 316
2021-06-30 $14,201 316